Characterization of some novel 1 -adrenoceptor antagonists in human hyperplastic prostate

By Chueh S.-C.   Chern J.-W.   Choong C.-M.   Guh J.-H.   Teng C.-M.  

European Journal of Pharmacology, Vol. 445, Iss. 1, 2002-06 ,pp. : 125-131

Elsevier

Access to resources Recommend Favorite

Contractile actions of imidazoline -adrenoceptor agonists and effects of noncompetitive 1 -adrenoceptor antagonists in human vas deferens

By Amobi N.   Guillebaud J.   Kaisary A.   Lloyd-Davies R.W.   Turner E.   Smith I.C.H.  

European Journal of Pharmacology, Vol. 462, Iss. 1, 2003-02 ,pp. : 169-177

Elsevier

Access to resources Recommend Favorite

Corrigendum to ''Contractile actions of imidazoline -adrenoceptor agonists and effects of noncompetitive 1 -adrenoceptor antagonists in human vas deferens'' [Eur. J. Pharmacol. 462 (2003) 169-177]

By Amobi N.   Guillebaud J.   Kaisary A.   Lloyd-Davies R.W.   Turner E.   Smith I.C.H.  

European Journal of Pharmacology, Vol. 464, Iss. 2, 2003-03 ,pp. : 241-241

Elsevier

Access to resources Recommend Favorite

Effects of α 1 -Adrenoceptor Antagonists on Male Sexual Function

By van Dijk Marleen M.  

Drugs, Vol. 66, Iss. 3, 2006-01 ,pp. : 287-301

Adis International

Access to resources Recommend Favorite

KMD-3213, a novel 1A -adrenoceptor antagonist, potently inhibits the functional 1 -adrenoceptor in human prostate

By Moriyama N.   Akiyama K.   Murata S.   Taniguchi J.   Ishida N.   Yamazaki S.   Kawabe K.  

European Journal of Pharmacology, Vol. 331, Iss. 1, 1997-07 ,pp. : 39-42

Elsevier

Access to resources Recommend Favorite